Kelland L: The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007, 7: 573-584. 10.1038/nrc2167.
Article
CAS
PubMed
Google Scholar
Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003, 22: 7265-7279. 10.1038/sj.onc.1206933.
Article
CAS
PubMed
Google Scholar
Perez RP: Cellular and molecular determinants of cisplatin resistance. Eur J Cancer. 1998, 34: 1535-1542. 10.1016/S0959-8049(98)00227-5.
Article
CAS
PubMed
Google Scholar
Gately DP, Howell SB: Cellular accumulation of the anticancer agent cisplatin - a review. Br J Cancer. 1993, 67: 1171-1176.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stewart DJ: Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol. 2007, 63: 12-31. 10.1016/j.critrevonc.2007.02.001.
Article
PubMed
Google Scholar
Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM: The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol. 2008, 48: 495-535. 10.1146/annurev.pharmtox.48.080907.180426.
Article
CAS
PubMed
Google Scholar
Katano K, Kondo A, Safaei R, Holzer A, Samimi G, Mishima M, Kuo YM, Rochdi M, Howell SB: Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res. 2002, 62: 6559-6565.
CAS
PubMed
Google Scholar
Safaei R, Holzer AK, Katano K, Samimi G, Howell SB: The role of copper transporters in the development of resistance to Pt drugs. J Inorg Biochem. 2004, 98: 1607-1613. 10.1016/j.jinorgbio.2004.05.006.
Article
CAS
PubMed
Google Scholar
Safaei R, Katano K, Samimi G, Naerdemann W, Stevenson JL, Rochdi M, Howell SB: Cross-resistance to cisplatin in cells with acquired resistance to copper. Cancer Chemother Pharmacol. 2004, 53: 239-246. 10.1007/s00280-003-0736-3.
Article
CAS
PubMed
Google Scholar
Samimi G, Katano K, Holzer AK, Safaei R, Howell SB: Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Mol Pharmacol. 2004, 66: 25-32. 10.1124/mol.66.1.25.
Article
CAS
PubMed
Google Scholar
Safaei R, Howell SB: Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol. 2005, 53: 13-23. 10.1016/j.critrevonc.2004.09.007.
Article
PubMed
Google Scholar
Safaei R: Role of copper transporters in the uptake and efflux of platinum containing drugs. Cancer Lett. 2006, 234: 34-39. 10.1016/j.canlet.2005.07.046.
Article
CAS
PubMed
Google Scholar
Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, Yang XL, Gao H, Miura N, Sugiyama T, Akiyama S: Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 2000, 60: 1312-1316.
CAS
PubMed
Google Scholar
Samimi G, Varki NM, Wilczynski S, Safaei R, Alberts DS, Howell SB: Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin Cancer Res. 2003, 9: 5853-5859.
CAS
PubMed
Google Scholar
Pena MM, Lee J, Thiele DJ: A delicate balance: homeostatic control of copper uptake and distribution. J Nutr. 1999, 129: 1251-1260.
CAS
PubMed
Google Scholar
Petris MJ, Mercer JFB, Culvenor JG, Lockhart P, Gleeson PA, Camakaris J: Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: A novel mechanism of regulated trafficking. EMBO J. 1996, 15: 6084-6095.
CAS
PubMed
PubMed Central
Google Scholar
Roelofsen H, Wolters H, van Luyn MJA, Miura N, Kuipers F, Vonk RJ: Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. Gastroenterology. 2000, 119: 782-793. 10.1053/gast.2000.17834.
Article
CAS
PubMed
Google Scholar
Katano K, Safaei R, Samimi G, Holzer A, Tomioka M, Goodman M, Howell SB: Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells. Clin Cancer Res. 2004, 10: 4578-4588. 10.1158/1078-0432.CCR-03-0689.
Article
CAS
PubMed
Google Scholar
Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M, Howell SB: Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res. 2004, 10: 4661-4669. 10.1158/1078-0432.CCR-04-0137.
Article
CAS
PubMed
Google Scholar
Zisowsky J, Koegel S, Leyers S, Devarakonda K, Kassack MU, Osmak M, Jaehde U: Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells. Biochem Pharmacol. 2007, 73: 298-307. 10.1016/j.bcp.2006.10.003.
Article
CAS
PubMed
Google Scholar
Molenaar C, Teuben JM, Heetebrij RJ, Tanke HJ, Reedijk J: New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy. J Biol Inorg Chem. 2000, 5: 655-665. 10.1007/s007750000153.
Article
CAS
PubMed
Google Scholar
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48: 589-601.
CAS
PubMed
Google Scholar
Fuchs R, Schmid S, Mellman I: A possible role for Na+,K+-ATPase in regulating ATP-dependent endosome acidification. Proc Natl Acad Sci U S A. 1989, 86: 539-543. 10.1073/pnas.86.2.539.
Article
CAS
PubMed
PubMed Central
Google Scholar
Altan N, Chen Y, Schindler M, Simon SM: Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med. 1998, 187: 1583-1598. 10.1084/jem.187.10.1583.
Article
CAS
PubMed
PubMed Central
Google Scholar
Petris MJ, Voskoboinik I, Cater M, Smith K, Kim BE, Llanos RM, Strausak D, Camakaris J, Mercer JF: Copper-regulated trafficking of the Menkes disease copper ATPase is associated with formation of a phosphorylated catalytic intermediate. J Biol Chem. 2002, 277: 46736-46742. 10.1074/jbc.M208864200.
Article
CAS
PubMed
Google Scholar
Schaefer M, Roelofsen H, Wolters H, Hofmann WJ, Muller M, Kuipers F, Stremmel W, Vonk RJ: Localization of the Wilson's disease protein in human liver. Gastroenterology. 1999, 117: 1380-1385. 10.1016/S0016-5085(99)70288-X.
Article
CAS
PubMed
Google Scholar
Bos K, Wraight C, Stanley KK: TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain. EMBO J. 1993, 12: 2219-2228.
CAS
PubMed
PubMed Central
Google Scholar
Molloy SS, Thomas L, VanSlyke JK, Stenberg PE, Thomas G: Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. EMBO J. 1994, 13: 18-33.
CAS
PubMed
PubMed Central
Google Scholar
Chapman RE, Munro S: Retrieval of TGN proteins from the cell surface requires endosomal acidification. EMBO J. 1994, 13: 2305-2312.
CAS
PubMed
PubMed Central
Google Scholar
Reaves B, Banting G: Vacuolar ATPase inactivation blocks recycling to the trans-Golgi network from the plasma membrane. FEBS Lett. 1994, 345: 61-66. 10.1016/0014-5793(94)00437-4.
Article
CAS
PubMed
Google Scholar
Gruenberg J, Maxfield FR: Membrane transport in the endocytic pathway. Curr Opin Cell Biol. 1995, 7: 552-563. 10.1016/0955-0674(95)80013-1.
Article
CAS
PubMed
Google Scholar
Tapper H, Sundler R: Bafilomycin A1 inhibits lysosomal, phagosomal, and plasma membrane H(+)-ATPase and induces lysosomal enzyme secretion in macrophages. J Cell Physiol. 1995, 163: 137-144. 10.1002/jcp.1041630116.
Article
CAS
PubMed
Google Scholar
Kalayda GV, Zhang G, Abraham T, Tanke HJ, Reedijk J: Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs. J Med Chem. 2005, 48: 5191-5202. 10.1021/jm050216h.
Article
CAS
PubMed
Google Scholar
Safaei R, Katano K, Larson BJ, Samimi G, Holzer AK, Naerdemann W, Tomioka M, Goodman M, Howell SB: Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells. Clin Cancer Res. 2005, 11: 756-767.
CAS
PubMed
Google Scholar
Chauhan SS, Liang XJ, Su AW, Pai-Panandiker A, Shen DW, Hanover JA, Gottesman MM: Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines. Br J Cancer. 2003, 88: 1327-1334. 10.1038/sj.bjc.6600861.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liang XJ, Shen DW, Garfield S, Gottesman MM: Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. Cancer Res. 2003, 63: 5909-5916.
CAS
PubMed
Google Scholar
Liang XJ, Shen DW, Gottesman MM: A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells. J Inorg Biochem. 2004, 98: 1599-1606. 10.1016/j.jinorgbio.2004.05.015.
Article
CAS
PubMed
Google Scholar
Kalayda GV, Jansen BAJ, Wielaard P, Tanke HJ, Reedijk J: Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthra-quinones: cellular processing in two cisplatin resistant cell lines reflects the differences in their resistance profiles. J Biol Inorg Chem. 2005, 10: 305-10.1007/s00775-005-0643-7.
Article
CAS
PubMed
Google Scholar
Schwartz AL: Cell biology of intracellular protein trafficking. Annu Rev Immunol. 1990, 8: 195-229. 10.1146/annurev.iy.08.040190.001211.
Article
CAS
PubMed
Google Scholar
Katzmann DJ, Babst M, Emr SD: Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell. 2001, 106: 145-155. 10.1016/S0092-8674(01)00434-2.
Article
CAS
PubMed
Google Scholar
Luzio JP, Pryor PR, Bright NA: Lysosomes: fusion and function. Nat Rev Mol Cell Biol. 2007, 8: 622-632. 10.1038/nrm2217.
Article
CAS
PubMed
Google Scholar
Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W, Howell SB: Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther. 2005, 4: 1595-1604. 10.1158/1535-7163.MCT-05-0102.
Article
CAS
PubMed
Google Scholar
Hall MD, Dillon CT, Zhang M, Beale P, Cai Z, Lai B, Stampfl APJ, Hambley TW: The cellular distribution and oxidation state of platinum (II) and platinum (IV) antitumor complexes in cancer cells. J Biol Inorg Chem. 2003, 8: 726-732. 10.1007/s00775-003-0471-6.
Article
CAS
PubMed
Google Scholar
Perego P, Caserini C, Gatti L, Carenini N, Romanelli S, Supino R, Colangelo D, Viano I, Leone R, Spinelli S, Pezzoni G, Manzotti C, Farrell N, Zunino F: A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system. Mol Pharmacol. 1999, 55: 528-534.
CAS
PubMed
Google Scholar